Radiation Therapy News and Research

RSS

Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.

VCU Massey Cancer Center introduces safer, more effective form of radiation therapy

Virginia Commonwealth University Massey Cancer Center has introduced a safer and more effective form of radiation therapy to treat cancer. The Center now offers volumetric modulated arc therapy (VMAT) delivery using the Philips Pinnacle3 SmartArc software to provide radiation treatment for multiple tumor sites, including prostate, head and neck, brain, breast and lung. VCU Massey is the first cancer center in the Richmond area to offer this cutting-edge radiation technique.

10 Jan 2011

Athersys completes patient enrollment in MultiStem Phase I study for leukemia

Athersys, Inc. today announced that it has completed patient enrollment of the single dose arm of a clinical study involving administration of MultiStem to patients being treated for leukemia or other blood born cancers.

7 Jan 2011

EUSA receives FDA Priority Review status for ERWINAZE BLA

EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that its Biologics License Application for ERWINAZE(R) has been accepted for filing and awarded Priority Review status by the U.S. Food and Drug Administration.

5 Jan 2011

BSD in final process of establishing international distribution networks for new microwave ablation product line

Maximizing production capacity, completing placement of systems in multiple hospitals, and witnessing early clinical successes with the MicroThermX Microwave Ablation line of products have paved the way for BSD Medical Corporation to take its sales and distribution strategy to the next level. BSD is in the final process of establishing both domestic and international distribution networks dedicated to selling its exciting new microwave ablation product line.

23 Dec 2010

In State budgets, Medicaid goes under the knife; Costs high for Florida Medicaid's doctor-immunity plan; N.J. practices to launch ACOs

Governors nationwide are taking a scalpel to Medicaid, the jointly run state and federal health-care program for 48 million poor Americans, half of whom are children. The single biggest expense for states, Medicaid consumes about 22 percent of their total $1.6 trillion in expenditures, more than what is allocated to elementary and secondary education, according to a National Governors Association report.

23 Dec 2010

Photon-based radiation therapy may result in better survival rate in patients with spinal-cord tumor

A study comparing the long-term outcomes of patients with spinal-cord tumors following radiation therapy suggests that certain subsets of patients have better long-term survival.

23 Dec 2010

NCI grants U-M Cancer Center $10.7M for study of colorectal and pancreatic cancer

The University of Michigan Comprehensive Cancer Center has received a five-year $10.7 million grant from the National Cancer Institute to study colorectal and pancreatic cancer.

23 Dec 2010

CHMP recommends to grant marketing authorization for Espriet drug against PF to CPF

The Coalition for Pulmonary Fibrosis announced to more than 128,000 patients news that the first drug for the treatment of the deadly lung disease Pulmonary Fibrosis has passed a major hurdle in the European regulatory process and is likely to be approved in all 27 member countries of the European Union.

22 Dec 2010

People with type 1 diabetes could grow their own insulin-producing cells, say researchers

At the annual meeting of the American Society for Cell Biology last week in Philadelphia, researchers from Georgetown University Medical Center in Washington, D.C., announced that it may be possible for people with type 1 diabetes to grow their own insulin-producing cells, a breakthrough that could lead to a cure for the disease.

22 Dec 2010

URI, R.I. Hospital to offer medical physics degree

Students interested in physics and medicine will be able to combine disciplines to become medical physicists and enter an expanding field that offers multiple career opportunities and salaries that start with six figures.

21 Dec 2010

Possible stem cell cure for AIDS

An explosion of stem cell breakthroughs, including a possible cure for AIDS, is reshaping the possibilities for curing deadly and debilitating diseases around the globe, says Emerging Healthcare Solutions President and CEO Cindy Morrissey.

17 Dec 2010

Alliance announces full year 2011 guidance, reaffirms 2010 financial guidance

Alliance HealthCare Services, Inc., a leading national provider of outpatient diagnostic imaging and radiation therapy services, reaffirmed full year 2010 guidance and announced financial guidance for full year 2011.

17 Dec 2010

Scientists decipher genetic code for pediatric medulloblastoma

Scientists at the Johns Hopkins Kimmel Cancer Center have deciphered the genetic code for medulloblastoma, the most common pediatric brain cancer and a leading killer of children with cancer.

16 Dec 2010

HIV patient cured!

German researchers working with stem cell therapy have claimed they have cured an American patient with HIV and leukemia. Experts are wary of accepting the development at its face value and caution that there is a need for further research. Dr David Scadden, a co-director of the Harvard University Stem Cell Institute added, “Cured is a strong word. But this is very encouraging… from all indications, there was no residual virus… It’s as good an outcome as one could hope for.”

16 Dec 2010

RAD to restore SCI's Radiation Treatment Center

Swedish Cancer Institute (SCI) has embarked on a bold approach to rapidly restore community-based radiotherapy cancer treatment in the Ballard community utilizing state-of-the-art building technology that is swift and green.

16 Dec 2010

Elekta to sell 49% stake in Motala Verkstad to Qeep

Elekta has signed an agreement to sell its 49 percent stake in Motala Verkstad AB. The buyer is Qeep Group.

From Elekta 15 Dec 2010

EHSI negotiates potential option agreement with Regenetech for Rotary Cell Culture System

Emerging Healthcare Solutions, Inc. is negotiating a potential option agreement with biotech firm Regenetech, Inc.

14 Dec 2010

CEL-SCI reports net income of $10.48M for fiscal 2010 vs. $40.9M loss for fiscal 2009

CEL-SCI Corporation reported financial results today for the fiscal year ended September 30, 2010.

13 Dec 2010

Prostate cancer study identifies 295 genes associated with clinical recurrence following radical prostatectomy

Genomic Health, Inc. today announced the first results of a large prostate cancer study that identified 295 genes strongly associated with clinical recurrence following radical prostatectomy. Top-line findings from this study, which applied the same RT-PCR technology used in Genomic Health's Oncotype DX® breast and colon cancer tests, will be presented today at the Society for Urologic Oncology (SUO) annual meeting.

13 Dec 2010

Study shows stereotactic radiation therapy as effective as surgery in elderly patients with early-stage lung cancer

A new study shows that a new type of targeted radiation therapy called stereotactic radiation therapy is just as good as surgery for patients aged 75 and older with early-stage lung cancer, according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (ISLAC) and the University of Chicago.

13 Dec 2010

Radiation Therapy News and Research

Further Reading

VCU Massey Cancer Center introduces safer, more effective form of radiation therapy

Athersys completes patient enrollment in MultiStem Phase I study for leukemia

EUSA receives FDA Priority Review status for ERWINAZE BLA

BSD in final process of establishing international distribution networks for new microwave ablation product line

In State budgets, Medicaid goes under the knife; Costs high for Florida Medicaid's doctor-immunity plan; N.J. practices to launch ACOs

Photon-based radiation therapy may result in better survival rate in patients with spinal-cord tumor

NCI grants U-M Cancer Center $10.7M for study of colorectal and pancreatic cancer

CHMP recommends to grant marketing authorization for Espriet drug against PF to CPF

People with type 1 diabetes could grow their own insulin-producing cells, say researchers

URI, R.I. Hospital to offer medical physics degree

Possible stem cell cure for AIDS

Alliance announces full year 2011 guidance, reaffirms 2010 financial guidance

Scientists decipher genetic code for pediatric medulloblastoma

HIV patient cured!

RAD to restore SCI's Radiation Treatment Center

Elekta to sell 49% stake in Motala Verkstad to Qeep

EHSI negotiates potential option agreement with Regenetech for Rotary Cell Culture System

CEL-SCI reports net income of $10.48M for fiscal 2010 vs. $40.9M loss for fiscal 2009

Prostate cancer study identifies 295 genes associated with clinical recurrence following radical prostatectomy

Study shows stereotactic radiation therapy as effective as surgery in elderly patients with early-stage lung cancer

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News